Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New antiinflammatory agents disclosed by DuPont Merck

Dec. 10, 1996

Sugen reports antihyperproliferative agents

Dec. 10, 1996

Merck & Co. reveals new agents for BPH

Dec. 10, 1996

Benzothiophene compounds for women's health disclosed by Lilly

Dec. 10, 1996

GRF analogs under study at Tulane University

Dec. 10, 1996

Therapeutically active NPY analog reported by academic source

Dec. 9, 1996

VIP analogs and derivatives claimed for smooth muscle relaxation

Dec. 9, 1996

New thrombin inhibitors under study at Merck & Co.

Dec. 9, 1996

Novo Nordisk claims dopamine D3 receptor ligands for CNS indications

Dec. 9, 1996

Bayer reveals sugar-modified cytostatic agents

Dec. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...